Foley Todd

CIK 000147393022 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001473930

Recent Transactions

50 trades

Conversion
Aktis Oncology, Inc.$AKTS
Series A Redeemable Convertible Preferred Stock
2026-01-12−10,227,273→ 0 total
Conversion
Aktis Oncology, Inc.$AKTS
Series Seed Redeemable Convertible Preferred Stock
2026-01-12−2,272,727→ 0 total
Conversion
Aktis Oncology, Inc.$AKTS
Series B Redeemable Convertible Preferred Stock
2026-01-12−2,727,273→ 0 total
Conversion
Aktis Oncology, Inc.$AKTS
Common Stock
2026-01-12+2,688,270→ 3,285,661 total
Conversion
Aktis Oncology, Inc.$AKTS
Common Stock
2026-01-12+716,872→ 4,002,533 total
Conversion
Aktis Oncology, Inc.$AKTS
Common Stock
2026-01-12+597,391→ 597,391 total
Purchase
Aktis Oncology, Inc.$AKTS
Common Stock
2026-01-12$18.00/sh+232,870→ 4,235,403 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2025-05-13$8.06/sh−630,191→ 2,108,594 total
Sale
Werewolf Therapeutics, Inc.$HOWL
Common Stock
2025-03-27$1.05/sh−1,963→ 3,208,793 total
Exercise of In-Money
Werewolf Therapeutics, Inc.$HOWL
Warrant (Right to Buy)
2025-03-27−18,743→ 0 total
Exercise of In-Money
Werewolf Therapeutics, Inc.$HOWL
Warrant (Right to Buy)
2025-03-27−4,015→ 0 total
Exercise of In-Money
Werewolf Therapeutics, Inc.$HOWL
Common Stock
2025-03-27$0.09/sh+22,758→ 3,210,756 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-12-11$20.23/sh−21,787→ 4,381,062 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-12-10$20.77/sh−22,935→ 4,402,849 total
Award
Repare Therapeutics Inc.$RPTX
Stock Option (right to buy)
2023-06-08+27,200→ 27,200 total
Other
TCR2 THERAPEUTICS INC.
Common Stock
2023-06-01−4,158,964→ 0 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2022-06-02+11,918→ 11,918 total
Award
Repare Therapeutics Inc.$RPTX
Stock Option (right to buy)
2022-05-13+49,000→ 49,000 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2022-01-05$42.03/sh−18,135→ 2,738,785 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2022-01-04$45.32/sh−6,768→ 2,764,591 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2022-01-04$43.20/sh−19,366→ 2,771,359 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2022-01-04$42.05/sh−94,745→ 2,790,725 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2022-01-04$46.47/sh−7,671→ 2,756,920 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-12-07$33.15/sh−17,962→ 2,886,964 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-12-07$34.11/sh−1,494→ 2,885,470 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-12-06$33.57/sh−1,171→ 2,905,494 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-12-06$34.08/sh−508→ 2,904,986 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-12-06$32.35/sh−8,469→ 2,906,665 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-12-06$35.04/sh−60→ 2,904,926 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-12-03$35.44/sh−2,419→ 2,915,313 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-12-03$34.68/sh−17,569→ 2,917,732 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-12-03$36.26/sh−179→ 2,915,134 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-12-02$33.74/sh−29,757→ 2,942,731 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-12-02$34.83/sh−7,430→ 2,935,301 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-12-01$34.61/sh−5,457→ 2,973,384 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-12-01$33.82/sh−6,042→ 2,978,841 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-12-01$35.34/sh−896→ 2,972,488 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-11-30$34.62/sh−5,861→ 3,012,959 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-11-30$35.19/sh−28,076→ 2,984,883 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-11-29$34.46/sh−10,073→ 3,019,118 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-11-29$35.37/sh−298→ 3,018,820 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-11-26$35.49/sh−6,545→ 3,035,320 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-11-26$36.03/sh−6,129→ 3,029,191 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-11-24$36.05/sh−18,343→ 3,054,991 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-11-24$35.20/sh−4,868→ 3,073,334 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-11-24$37.02/sh−13,126→ 3,041,865 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-11-23$36.50/sh−359→ 3,078,202 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-11-23$36.21/sh−19,645→ 3,078,561 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-11-22$37.81/sh−11,807→ 3,098,206 total
Sale
iTeos Therapeutics, Inc.
Common Stock
2021-11-22$37.16/sh−9,307→ 3,110,013 total

Recent Filings

Address

C/O MPM BIOIMPACT LLC 399 BOYLSTON STREET, SUITE 1100

BOSTON, MA, 02116

View on SEC.gov